Chemistry: natural resins or derivatives; peptides or proteins; – Peptides of 3 to 100 amino acid residues – Cyclic peptides
Reexamination Certificate
2006-05-16
2006-05-16
Weber, Jon P. (Department: 1653)
Chemistry: natural resins or derivatives; peptides or proteins;
Peptides of 3 to 100 amino acid residues
Cyclic peptides
C514S011400, C514S017400, C530S318000, C530S328000, C530S330000
Reexamination Certificate
active
07045591
ABSTRACT:
Peptides cyclized via disulfide or lactam bridges are disclosed. The peptides exhibit melanocortin-4 receptor agonist activity and are useful for treating obesity.
REFERENCES:
patent: 5811391 (1998-09-01), Arrhenius et al.
patent: 5858972 (1999-01-01), Pierschbacher et al.
patent: WO 00/58361 (2000-10-01), None
Fan et al., Nature, vol. 385, pp. 165-168 (1997).
Cone et al., Rec. Prog. Hormone Research, vol. 51, pp. 287-318 (1996).
Haskell-Luevano et al., Peptides, vol. 17, No. 6, pp. 995-1002 (1996).
R. B. Merrifield, J. Amer. Chem. Soc., vol. 85, pp. 2149-2154 (1963).
Barany et al., The Peptides, Analysis, Synthesis and Biology, vol. 2, E. Gross and J. Meienhofer, Eds. Academic Press, pp. 1-284 (1980).
Kaiser et al., Anal. Biochem., 34, pp. 595-598 (1970).
Obrecht et al., Helv. Chim. Acta, vol. 75, pp. 1666-1696 (1992).
Freeman et al., J. Org. Chem., vol. 54, pp. 782-789 (1989).
Boteju et al., Tet. Lett., 33 p. 7491-7494 (1992).
Nicholas et al., J. Org. Chem. 58, pp. 766-770 (1993).
Bednarek et al., Biochem. Biophys. Res. Comm. 261, pp. 209-213 (1999).
Bednarek et al., Peptides 20, pp. 401-409 (1999).
Adan E.A.,European Journal of Pharmacology, vol. 378, pp. 249-258 (1999).
Benoit E.A.,J. Neuroscience, vol. 20, No. 9, pp. 3442-3448, (2000).
Bednarek, M.A., et al., Biochemical and Biophysical Research Communications, Academic Press, vol. 272, No. 1, pp. 23-28 (2000).
Chen Li
Cheung Adrian Wai-Hing
Chu Xin-Jie
Danho Waleed
Swistok Joseph
Hoffmann-La Roche Inc.
Johnston George W.
Lukton David
Tramaloni Dennis P.
Weber Jon P.
LandOfFree
Selective cyclic peptides with melanocortin-4 receptor... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Selective cyclic peptides with melanocortin-4 receptor..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Selective cyclic peptides with melanocortin-4 receptor... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3524952